AIM ImmunoTech Inc. (AIM) Q4 2024 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Aim Immunotech Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.416 Hello and welcome to the AIM Immunotech fourth quarter and full year 2024 update conference 00:00:05.416 -- 00:00:07.538 call and webcast. 00:00:07.538 -- 00:00:11.822 As a brief reminder, all participants are currently in a listen-only mode. 00:00:11.822 -- 00:00:16.467 If anyone requires operator assistance during the event, please press star zero on your 00:00:16.467 -- 00:00:18.589 telephone keypad. 00:00:18.589 -- 00:00:22.132 Following the presentation will be a question and answer session. 00:00:22.132 -- 00:00:26.516 Note that this webcast is being recorded at the company's request and a replay will be 00:00:26.516 -- 00:00:30.743 made available on the company's website following the end of the event. 00:00:30.743 -- 00:00:34.289 At this time, I'd like to remind our listeners that remarks made during the webcast may 00:00:34.289 -- 00:00:38.997 state management's intentions, beliefs, expectations, or future projections. 00:00:38.997 -- 00:00:42.723 These are forward-looking statements that involve risks and uncertainties. 00:00:42.723 -- 00:00:46.069 Forward-looking statements on this call are made pursuant to the safe harbor provisions 00:00:46.069 -- 00:00:50.516 of the Federal Securities Law Center based on AIM Immunotech's current expectations and 00:00:50.516 -- 00:00:53.121 actual results could differ materially. 00:00:53.121 -- 00:00:57.963 As a result, you should not place undue reliance on any forward-looking statements. 00:00:57.963 -- 00:01:02.491 Some of the factors that could cause actual results to differ materially from these contemplated 00:01:02.491 -- 00:01:07.941 by such forward-looking statements are discussed in the periodic reports in METOTEC files 00:01:07.941 -- 00:01:10.826 with the Securities and E...